201 related articles for article (PubMed ID: 15269454)
1. Impact of stage differentiation on diagnosis of toxoplasmosis.
Gross U; Holpert M; Goebel S
Ann Ist Super Sanita; 2004; 40(1):65-70. PubMed ID: 15269454
[TBL] [Abstract][Full Text] [Related]
2. [Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification].
Darcy F; Torpier G; Cesbron-Delauw MF; Decoster A; Ridel PR; Duquesne V; Charif H; Godard I; Pierce RJ; Auriault C
Ann Biol Clin (Paris); 1989; 47(7):451-7. PubMed ID: 2479305
[TBL] [Abstract][Full Text] [Related]
3. Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection.
Decoster A; Darcy F; Capron A
Clin Exp Immunol; 1988 Sep; 73(3):376-82. PubMed ID: 3208449
[TBL] [Abstract][Full Text] [Related]
4. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
Piergili Fioretti D
Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro.
Soete M; Fortier B; Camus D; Dubremetz JF
Exp Parasitol; 1993 May; 76(3):259-64. PubMed ID: 7684705
[TBL] [Abstract][Full Text] [Related]
6. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host.
Ferguson DJ
Int J Parasitol; 2004 Mar; 34(3):347-60. PubMed ID: 15003495
[TBL] [Abstract][Full Text] [Related]
7. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity.
Lappalainen M; Hedman K
Ann Ist Super Sanita; 2004; 40(1):81-8. PubMed ID: 15269456
[TBL] [Abstract][Full Text] [Related]
8. [Antigens of Toxoplasma gondii].
Długońska H; Dytnerska K
Wiad Parazytol; 2000; 46(3):327-34. PubMed ID: 16883687
[TBL] [Abstract][Full Text] [Related]
9. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies.
Béla SR; Oliveira Silva DA; Cunha-Júnior JP; Pirovani CP; Chaves-Borges FA; Reis de Carvalho F; Carrijo de Oliveira T; Mineo JR
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):245-54. PubMed ID: 18703303
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of chronic toxoplasmosis: is there a link to strain-specific differences in the parasite?
Gross U; Kempf MC; Seeber F; Lüder CG; Lugert R; Bohne W
Behring Inst Mitt; 1997 Mar; (99):97-106. PubMed ID: 9303208
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts.
Nielsen HV; Di Cristina M; Beghetto E; Spadoni A; Petersen E; Gargano N
Exp Parasitol; 2006 Apr; 112(4):274-9. PubMed ID: 16368092
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
[TBL] [Abstract][Full Text] [Related]
13. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.
Pfrepper KI; Enders G; Gohl M; Krczal D; Hlobil H; Wassenberg D; Soutschek E
Clin Diagn Lab Immunol; 2005 Aug; 12(8):977-82. PubMed ID: 16085916
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
15. Protective Th1 immune responses against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart.
Jongert E; Verhelst D; Abady M; Petersen E; Gargano N
Vaccine; 2008 Sep; 26(41):5289-95. PubMed ID: 18675872
[TBL] [Abstract][Full Text] [Related]
16. [Antigens of Toxoplasma gondii].
Długońska H; Dytnerska K
Wiad Parazytol; 1999; 45(4):473-80. PubMed ID: 16888988
[TBL] [Abstract][Full Text] [Related]
17. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
Innes EA; Vermeulen AN
Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of the specific humoral and cellular response to Toxoplasma gondii in a patient with acquired toxoplasmosis.
Derouin F; Rabian-Herzog C; Sulahian A
J Clin Lab Immunol; 1989 Oct; 30(2):97-102. PubMed ID: 2641536
[TBL] [Abstract][Full Text] [Related]
19. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts.
Beghetto E; Nielsen HV; Del Porto P; Buffolano W; Guglietta S; Felici F; Petersen E; Gargano N
J Infect Dis; 2005 Feb; 191(4):637-45. PubMed ID: 15655789
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein 1 (MIC1) for detection of immunoglobulin G antibodies.
Holec L; Gasior A; Brillowska-Dabrowska A; Kur J
Exp Parasitol; 2008 May; 119(1):1-6. PubMed ID: 18207143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
